SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech - Technical Analysis -- Ignore unavailable to you. Want to Upgrade?


To: Jibacoa who wrote (505)8/9/2002 10:58:07 AM
From: Jibacoa  Read Replies (1) | Respond to of 544
 
ORCH Is trying to continue yesterday's move. It reported a 145% increase in revenues for its second Q, but its net loss also increased by 15%.<g>

It also had announced on Wednesday that it had settled its dispute with St.Louis Univ. concerning a patent dispute.<g>

At any rate, it seems to have found support at the 0.90 level with the 7/31-8/1-8/2-8/5 quadruple bottom.<g>

siliconinvestor.com

siliconinvestor.com

I bought some recently since the R/R appears to be favorable, but don't plan to add more until it can close above 2.<g>

siliconinvestor.com

Bernard



To: Jibacoa who wrote (505)8/13/2002 3:43:20 PM
From: Jibacoa  Read Replies (1) | Respond to of 544
 
DNDN Continues the up-move.<g>

It is up 33.77% after DNA said it will pay as much as 100 M for the right to co-develop cancer drugs based on a gene known as Trp-p8, which was discovered by DNDN.<g>

siliconinvestor.com

siliconinvestor.com

Bernard